Abstract
Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Current Nanomedicine
Title:Nanoceria: A Novel Cytoprotective Drug Delivery Carrier
Volume: 7 Issue: 2
Author(s): Jawahar Natarajan*Sukumar Nagavishwakya
Affiliation:
- JSS College of Pharmacy, JSS University, Mysore - Pharmaceutics Ootacamund, Tamil Nadu,India
Keywords: Nanoceria, cerium oxide nanoparticle (CNP), cytoprotective, reactive oxygen species (ROS), oxidative stress, novel carrier.
Abstract: Nanotechnology is an advancing field of biomedical science especially in drug delivery system. Nanoceria a part of nanotechnology will appear as an innovative drug delivery carrier in various therapies. The unique ability of nanoceria to switch its oxidation state between +3 and +4 makes it a potent therapeutic option for many diseases associated with oxidative stress, inflammation and also a potent drug delivery agent.
Description: In this review article, we focus the main drug delivery mechanisms (autoregeneration and radical scavenger) of nanoceria and its synthesis, characterization, toxicity; application with respect to reactive oxygen species (ROS) mediated disorders.Export Options
About this article
Cite this article as:
Natarajan Jawahar*, Nagavishwakya Sukumar, Nanoceria: A Novel Cytoprotective Drug Delivery Carrier, Current Nanomedicine 2017; 7 (2) . https://dx.doi.org/10.2174/2468187307666170208104644
DOI https://dx.doi.org/10.2174/2468187307666170208104644 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |
Call for Papers in Thematic Issues
Nanomaterials for Drug Delivery System in Chronic and Infectious Disease Therapy
The exploration of nanomaterials for drug delivery systems represents a cutting-edge frontier in modern medical research. In our Thematic Issue, we delve into the extensive scope of utilizing nanotechnology to combat chronic and infectious diseases. This emerging field holds tremendous promise, offering innovative solutions to longstanding challenges in healthcare. At ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
Current Neuropharmacology Regulatory Considerations for Generic or Biosimilar Low Molecular Weight Heparins
Current Drug Discovery Technologies Astrocytic 5-HT2B Receptor as in vitro and in vivo Target of SSRIs
Recent Patents on CNS Drug Discovery (Discontinued) An update on Anti-inflammatory Compounds: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Neuroprotective and Preventative Effects of Molecular Hydrogen
Current Pharmaceutical Design The Surgical Management of Parkinson's Disease
CNS & Neurological Disorders - Drug Targets The Role of Adenosine in Rheumatoid Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Cellular Niches for Endogenous Neural Stem Cells in the Adult Brain
CNS & Neurological Disorders - Drug Targets Orofacial Pain and Mastication in Dementia
Current Alzheimer Research Antioxidant Nanoparticles for Control of Infectious Disease
Infectious Disorders - Drug Targets The Use of Dexmedetomidine in Anesthesia and Intensive Care: A Review
Current Pharmaceutical Design The Utility of Interappendicular Connections in Bipedal Locomotion
Current Pharmaceutical Design Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Current Drug Abuse Reviews GABAB Receptors-Associated Proteins: Potential Drug Targets in Neurological Disorders?
Current Drug Targets Integrin α4β7 Antagonists: Activities, Mechanisms of Action and Therapeutic Prospects
Current Immunology Reviews (Discontinued) Cancer and Treatment Modalities
Current Cancer Therapy Reviews Phosphatidylserine and Curcumin Act Synergistically to Down-Regulate Release of Interleukin-1β from Lipopolysaccharide-Stimulated Cortical Primary Microglial Cells
CNS & Neurological Disorders - Drug Targets Pathophysiology of Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews PAX6 expression may be protective against dopaminergic cell loss in Parkinson’s disease
CNS & Neurological Disorders - Drug Targets Effects of Maternal Obesity on Maternal and Fetal Health
Current Women`s Health Reviews